NK(1) receptor and its interaction with NMDA receptor in spinal c-fos expression after lower urinary tract irritation.
The role of neurokinin 1 (NK(1)) receptor and possible interaction between NK(1) and N-methyl-D-aspartic acid (NMDA) glutamatergic receptors were investigated on spinal c-fos expression after lower urinary tract irritation with acetic acid infusion in rats. At both levels of the first (L(1)) and sixth lumbar (L(6)) spinal cord, where most of hypogastric nerve and pelvic nerve afferent terminals project, respectively, the selective NK(1) receptor antagonist CP-99,994 dose dependently reduced the total number of c-fos protein (Fos)-positive cells. However, CP-100,263, the enantiomer of CP-99,994 with a very low affinity for NK(1) receptor, did not have any effect on the total number of Fos-positive cells. Coadministration of a low dose (1 mg/kg) of CP-99,994 and NMDA receptor antagonist (MK-801), either of which alone did not affect c-fos expression, significantly inhibited c-fos expression at both levels of the spinal cord. Regarding regional differences, the number of Fos-positive cells decreased significantly at all regions of the L(6) level, but only at the dorsal horn of the L(1) level. These results indicate that NK(1) receptor is involved in spinal c-fos expression after lower urinary tract irritation and that NK(1) and NMDA receptors have a synergistic interaction in the spinal processing of nociceptive input from the lower urinary tract.
Mitsui
Takahiko
T
Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, 060 - 8638, Japan. mitsui68@med.hokudai.ac.jp
Kakizaki
Hidehiro
H
Matsuura
Shinobu
S
Tanaka
Hiroshi
H
Ameda
Kaname
K
Yoshioka
Mitsuhiro
M
Koyanagi
Tomohiko
T
D019342:Acetic Acid; D000818:Animals; D003556:Cystitis / Q000139:chemically induced; D016291:Dizocilpine Maleate / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005260:Female; D007509:Irritants; D009619:Nociceptors / Q000502:physiology; D010880:Piperidines / Q000494:pharmacology; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis*; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D018040:Receptors, Neurokinin-1 / Q000378:metabolism*; D013116:Spinal Cord / Q000378:metabolism*; D001743:Urinary Bladder / Q000294:innervation*
D018691:Excitatory Amino Acid Antagonists; D007509:Irritants; D010880:Piperidines; D016760:Proto-Oncogene Proteins c-fos; D016194:Receptors, N-Methyl-D-Aspartate; D018040:Receptors, Neurokinin-1; C080755:3-(2-methoxybenzylamino)-2-phenylpiperidine; D016291:Dizocilpine Maleate; D019342:Acetic Acid